VXRT

Open Orphan hVIVO to develop the world’s first Omicron human challenge model

Vaxart becomes the first client of the programme to test its oral COVID-19 vaccine candidate Open Orphan plc (LON:ORPH), a rapidly growing specialist contract research organisation (CRO) and world..

Search

Funds

VXRT

Search

Funds

VXRT

FTSE 100

Funds